Participants

Participating companies

Around 400 international AMR experts from industry, SMEs, start-ups, big pharma, academia, clinics, regulatory bodies, investors, public institutions and policy will meet on 12–13 March in Basel at the 4th AMR Conference to network and discuss challenges and strategies for bringing new antimicrobial treatments and diagnostics to the market.

See who is already registered:

A
Aalto University
ABAC THERAPEUTICS SL
Accelerate Diagnostics
AFRD
AGILeBiotics B.V.
AiCuris Anti-infective Cures GmbH
AID GmbH
AIM
Allecra Therapeutics
Amin Pharmacy
Amprologix
AMR Centre Ltd
AnalytiCon Discovery
ANTABIO SAS
APCONIX
Arcis Biotechnology
Ares Genetics
Ascenion GmbH
Asclepia Outsourcing Solutions BVBA
ATG:biosynthetics GmbH
Axonlab AG

B
Bachem AG
Bacoba AG
Basilea Pharmaceutica International Ltd.
BEAM Alliance
BI Pharma GmbH & Co. KG
Bill & Melinda Gates Foundation
Biofilm Pharma
bioMérieux
bioMérieux/VALUE-Dx
BiosparQ bv
BioSystems Technology
Biotaspheric
BioTherapeutics
BioVersys
BioVersys AG
Biozentrum, The Center for Moleculare Life Sciences, University of Basel
Boehringer Ingelheim Pharma GmbH & Co. KG
Boehringer Ingelheim Venture Fund GmbH
BPI (Bundesverband der Pharmazeutischen Industrie / German Pharmaceutical Industry Association)
British Embassy
British Embassy Vienna
Broad Institute
BUGWORKS

C
CARB-X
CEIDR Innovations
Cellics Therapeutics, Inc.
Center for Advanced Studies in Biomedical Innovation Law (CeBIL)
Center for Anti-Infective Agents
Center for Infectious Diseases and Infection Control, Jena University Hospital
Centre of Excellence in Infectious Diseases Research (CEIDR), University of Liverpool
Chemgineering.Technology AG
CimArk SA
Clemedi AG
Collaborative Drug Discovery (CDD)
Combioxin SA
Curetis N. V.

D
Da Volterra
Debiopharm International SA
Destiny Pharma plc
dispendix
DLR Project Management Agency

E
ENABLE
ETH Zürich
ETH Zürich / SpheroBiotics
European Investment Bank
EVOTEC ID SAS

F
F. Hoffmann-La Roche Ltd
Federal Institute for Drugs and Medical Devices (BfArM)
Federal Ministry of Education and Research Germany
FluoretiQ Limited
Food and Drug Administration (FDA)
Foundation for Innovative New Diagnostics
Fraunhofer IME
Fraunhofer ITEM
Fraunhofer IZI-BB
FRIZ Biochem GmbH
Fundacion MEDINA

G
GARB-X
GARDP Foundation
GBA Group Pharma
Genexa AG
Genomtec
German Center for Infection Research (DZIF)
GlaxoSmithKline
Global AMR R&D Hub
grit42

H
Hans Knöll Institute (HKI)
HAPILA GmbH
Helmholtz Centre for Infection Research (HZI) / German Center for Infection Research
Helmholtz Institute for Pharmaceutical Research Saarland
HEMEX AG
HYpharm GmbH

I
ICARS
Idorsia Pharmaceuticals Ltd
IHMA Europe
Imbbarco GmbH
InfectControl
InfectoGnostics Research Campus Jena
INSTITUT PASTEUR
Institute of Hygiene
Institute of Medical Microbiology, University of Zürich
Intergrated BioTherapeutics Inc
International Centre for AMR Solutions

J
Jacobs University Bremen
JNCASR
Julius Clinical
Juvabis AG

K
Klivofet AG

L
Lady Hardinge Medical College & Kalawati Saran
Leibniz Health Technologies
Leibniz Institute for Health Technologies (IPHT)
Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute
Leibniz-HKI
LifeArc
LimmaTech Biologics
Lisando GmbH
Liverpool School of Tropical Medicine (LSTM)
Ludwig-Maximilians-University Munich (LMU)
Lygature
LYO-X GmbH

M
Madam Therapeutics
Magic Bullet Consulting
Malcolm Page GmbH
Med. Microbiology
Medical Trials Analysis Swiss SA
Medical University of Graz
Medicines Discovery Catapult
Micron Research Ltd
Microsynth AG
Ministry of Agriculture, Animal Industry and Fisheries, Uganda
Ministry of Agriculture, Animal Industry and Fisheries,Entebbe, Uganda
Morton Findlay Associates Ltd
Mundipharma International
MUTABILIS
Myxobiotics

N
NADP
National Institute for Health Research, UK
National Research Council Canada
National University of Medical Sciences
Nesta / Longitude Prize
Netherlands Antibiotic Development Platform
NICE
NIH
Noscendo GmbH
NOSOPHARM
NovaBiotics Ltd
Novo Holdings, REPAIR Impact Fund
NRP 72 “Antimicrobial Resistance”
Nuritas Ltd.
NZZ am Sonntag

O
Omnix Medical
Oxford Drug Design Limited

P
Pasteur Institute of Iran
Paul-Ehrlich-Institute
Pedanius Therapeutics Limited
PerioTrap Pharmaceuticals GmbH
Perseo Pharma AG
Pfizer
PhagoMed Biopharma GmbH
PharmaBoardroom
Pharmacology Discovery Services
PhAST Corp.
Polyphor AG
PSI CRO AG

Q
QuantuMDx
QureTech Bio AB

R
Ratatoa Consulting
Resistell
Resistomap Oy
Royal Veterinary College

S
SDC Swiss Agency for Development and Cooperation
Sefunda AG
Selmod GmbH
Sensirion AG
SGS Belgium NV
Sidanis Pharma
Soladis GmbH
South Centre
Space Peptides
SpeeDx
SpheroBiotics
SSI
Statens Serum Institut
Summit Therapeutics
Suspire
Swiss Biotech Assiociation (SBA)
swissinfo.ch (SRG)
Symcel
Synbactis Inc.

T
Technical University Munich
Terrapinn
The Ad Astra Team
TLSC GmbH / Biotaspheric Ltd
TNO
tranScrip
Triangulate Health Ltd

U
UiT The Arctic University of Norway
UK Department for International Trade
UNCTAD
UNIBAS
Unitaid
United Nations Conference on Trade and Development
Univ. Hospital Cologne, Inst. Med. Microbiology
Univeristy Basel
Universidad Carlos III de Madrid
Universität Zürich
Universitätsklinikum Tübingen
University Clinic Jena
University Giessen / DZIF
University Giessen / DZIF
University Hospital Bonn
University Hospital Cologne
University Medical Center Utrecht
University of Basel
University of Cagliari
University of California
University of Copenhagen
University of Edinburgh
University of Gießen
University of Liverpool
University of Oxford
University of Pennsylvania
University of Tartu, Institute of Technology
University of Tübingen
University of Zurich

V
Vaxxilon AG
VDI Technologiezentrum GmbH
Venus Medicine Research Centre
Vibiosphen SAS
Vitamica Ltd
VIVEXIA

W
Wellcome Trust
Wellspring ID
WHO
World Health Organization (WHO)
WuXi AppTec

X
XELLIA